BIOMAT Database Logo BIOMAT Database Logo

Pharmacology and pharmacokinetics of danazol. 1980

G O Potts, and H P Schane, and J Edelson

UI MeSH Term Description Entries
D007030 Hypothalamo-Hypophyseal System A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine (HYPOTHALAMIC HORMONES) regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS. Hypothalamic Hypophyseal System,Hypothalamo-Pituitary-Adrenal Axis,Hypophyseal Portal System,Hypothalamic-Pituitary Unit,Hypothalamic Hypophyseal Systems,Hypothalamic Pituitary Unit,Hypothalamo Hypophyseal System,Hypothalamo Pituitary Adrenal Axis,Portal System, Hypophyseal
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011245 Pregnadienes Pregnane derivatives containing two double bonds anywhere within the ring structures.
D003613 Danazol A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders. Azol,Cyclomen,Danatrol,Danazant,Danazol-Ratiopharm,Danocrine,Danol,Danoval,Ladogal,Norciden,Panacrine,Danazol Ratiopharm
D006066 Gonads The gamete-producing glands, OVARY or TESTIS. Gonad
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

G O Potts, and H P Schane, and J Edelson
Pharmacology of danazol.
January 1977, The Journal of international medical research,
G O Potts, and H P Schane, and J Edelson
Pharmacology and clinical effects of danazol.
July 1982, American journal of obstetrics and gynecology,
G O Potts, and H P Schane, and J Edelson
Danazol: molecular, endocrine, and clinical pharmacology.
January 1990, Progress in clinical and biological research,
G O Potts, and H P Schane, and J Edelson
Danazol: endocrine pharmacology and therapeutic applications.
October 1981, American journal of obstetrics and gynecology,
G O Potts, and H P Schane, and J Edelson
Comparison of the pharmacology of nafarelin and danazol.
February 1990, American journal of obstetrics and gynecology,
G O Potts, and H P Schane, and J Edelson
Effect of danazol on cyclosporine pharmacokinetics.
May 1988, Transplantation,
G O Potts, and H P Schane, and J Edelson
Pharmacokinetics of cyclosporin during administration of danazol.
January 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
G O Potts, and H P Schane, and J Edelson
Basic pharmacology and pharmacokinetics.
April 1992, Clinics in podiatric medicine and surgery,
G O Potts, and H P Schane, and J Edelson
Fulvestrant: pharmacokinetics and pharmacology.
March 2004, British journal of cancer,
G O Potts, and H P Schane, and J Edelson
[Pharmacokinetics and clinical pharmacology].
May 1973, Bollettino chimico farmaceutico,
Copied contents to your clipboard!